ZOLASTA 4MG INJECTION contains
Zoledronic Acid
, which belongs to the group of medicines called Bisphosphonates. It is used to manage bone complications such as fractures and bone metastases (cancer that has spread from the original (primary) tumour to the bone) in adult patients and helps to reduce the amount of calcium in the blood in adult patients (tumour-induced hypercalcaemia (TIH)).
Along with management with ZOLASTA 4MG INJECTION, your doctor might ask you to make some lifestyle changes, such as eating a balanced diet rich in calcium and vitamin D. Prior to starting management with ZOLASTA 4MG INJECTION, your doctor might want you to take some diagnostic tests to understand the existing condition.
Before receiving ZOLASTA 4MG INJECTION, inform your doctor if you have had or have pain, swelling or numbness of the jaw, a feeling of heaviness in the jaw or loosening of teeth, kidney disease, are having dental management, or are due to undergo dental surgery.
ZOLASTA 4MG INJECTION is not recommended for use in pregnant and breast-feeding women. ZOLASTA 4MG INJECTION is not recommended for use in children and adolescents (under 18 years of age) and should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before receiving ZOLASTA 4MG INJECTION.
The most common side effects of receiving ZOLASTA 4MG INJECTION are headache, nausea, vomiting, loss of appetite, conjunctivitis, and anemia (a low number of red blood cells). Inform your doctor if any of the symptoms worsen.
No content available
